Prenatal Fine Particulate Matter Exposure Linked to Cerebral Palsy

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, July 12, 2024 -- Prenatal ambient fine particulate matter (PM2.5) exposure is associated with an increased risk for cerebral palsy, according to a study published online July 9 in JAMA Network Open.

Yu Zhang, Ph.D., from the Harvard T.H. Chan School of Public Heath in Boston, and colleagues examined the associations between prenatal residential exposure to ambient air pollution and the risk for CP among children born at term gestation in a population-based cohort study conducted in Ontario, Canada. Data were included for 1,587,935 mother-child pairs who reached term gestation; 3,170 (0.2 percent) children were diagnosed with CP.

The researchers found that the cumulative hazard ratio was 1.12 (95 percent confidence interval, 1.03 to 1.21) for CP in association with a per-interquartile range increase (2.7 µg/m3) in prenatal PM2.5 concentration. The cumulative hazard ratio was higher for male than female infants (1.14 [95 percent CI, 1.02 to 1.26] versus 1.08 [95 percent CI, 0.96 to 1.22]). In the study population, there was no specific window of susceptibility noted for prenatal PM2.5 exposure and CP. For prenatal nitrogen dioxide and ozone exposure, no associations or windows of susceptibility were found for CP risk.

"The findings of this large cohort study could advance the identification of existing environmental risk factors for CP development and better inform interventions to mitigate the potential risk of CP during fetus development," the authors write. "Further studies are needed to validate the associations and explore potential modifiers."

One author reported receiving personal fees from Pfizer.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-13 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords